Page 1926 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Index 1353

Remifentanil, 151 regression to the mean in, 9–10, 9t detecting reversible features,
Remote monitoring, 64 secular trends in, 9t, 10 519, 519t
Renal abscess, 700 statistical control charts for performance effects on pulmonary circulation, 518
sickle cell disease and, 907 monitoring in, 9t gas exchange, 518
Renal adaptation in pregnancy, 1255 Respiratory abnormalities, ventilator laboratory abnormalities, 517–518
Renal cysts, 700–701 management of, 458–459, 458f, long-term management of
Renal dysfunction, electric trauma and, 459f, 460f, 461ft, 462t, 463ft, 464t, idiopathic, 520
1177–1178 465t, 467f outcome, 518–519
Renal evaluation, in organ transplantation, Respiratory acid-base disorders oxygen therapy, 519
1113, 1113f acid-base balance and, 974 respiratory mechanics, 518
Renal excretion, 1230–1232 pathophysiology of, 974 ventilator management of, 519–520
https://kat.cr/user/tahir99/
Renal failure Respiratory alkalosis, 497, 951, 974 thoracic cage deformity, 513–515,
acid-base balance and, 971–972 Respiratory complications, with spinal 513t, 514f
assessment of, 208 injuries, 1143–1144, 1143f effects on pulmonary circulation, 515
systemic lupus erythematosus Respiratory conditions requiring gas exchange, 515
and, 1242 extracorporeal membrane respiratory mechanics, 514,
Renal function, monitoring, in intensive care oxygenation (ECMO), 514f, 515f
unit, 922–923, 923f 470, 471t Resuscitation
RenalGuard system, 921 Respiratory disease complicating HIV catheters and monitoring during
Renal insufficiency, interventional radiology infection, 629, 629f initial, 254
and, 209 Respiratory disorders red blood cell transfusion during, 252
Renal replacement therapy, 549–550 acid-base balance and, 969 Resuscitation goals, in burn patients,
defined, 933 in pregnancy, 1264–1268 184, 1185f
dose of therapy, 938–939, 940t in sepsis, 565 Reteplase, 299
future directions, 942–943 Respiratory failure Reticular activating system, 830–831
indications for and timing of initiation, neuromuscular diseases leading to, 8 Retiform purpura, 1294, 1295f
933–934, 933t, 935t 23–828 Retinoic acid syndrome, 895
in intensive care unit, 932–943 obesity and, 1308–1309, 1309f Retroperitoneal hemorrhage, 1166
modality of polymyositis/dermatomyositis and, 1244 Retropharyngeal abscesses, 683
acid-base disturbance, 937 Respiratory infections in pregnancy, Reynold pentad, 999
acute liver failure, 936–937 1265–1266 Rhabdomyolysis, 977, 1213
acute-neurologic injury, 937 Respiratory management, head injury and, Rhabdoviridae, 673
diffusive versus convective 1125–1126 Rheumatoid arthritis, 409, 826, 1244–1245
therapies, 938 Respiratory mechanics, abnormalities in, Rheumatoid factor, 1249
hyperphosphatemia, 937 373–374, 373f, 374f Rheumatologic diseases in intensive care
intermittent versus continuous delivery, Respiratory muscle fatigue, 485, 516 unit (ICU), outcomes of patients
934–936 Respiratory muscle weakness, with, 1245
severe sepsis, 937–938 821–823, 823f Rheumatology in intensive care unit (ICU),
supportive care Respiratory syncytial virus, infection control 1241–1253
medication dosing, 942 and, 30–31 abdominal pain and elevated erythrocyte
nutritional support, 941–942 Respiratory system, adaptation of, in sedimentation rate, 1246
sepsis and, 574–575 pregnancy, 1255, 1255t autoinflammatory diseases, 1245
technical aspects Respiratory therapists, intensive-care unit central nervous system dysfunction,
access, 939–940 staffing by, 21–22 1246–1247
anticoagulation, 940–941 Respiratory therapy equipment and elderly patient with elevated sedimentation
Renal salt wasting, 1128 nasogastric tubes, 25–26, 26t rate, 1246
Renal syndrome, hemorrhagic fever with, Respiratory tract infection, 645 empirical therapy for suspected rheumatic
742–743 Respiratory virus infections, 617 disease, 1253
Renal toxicities, 898–899, 899t Restaurant syndromes, 1275 interpretation of rheumatology laboratory
Renal transplantation, acute renal failure Reston ebolavirus, 740 abnormalities in, 1247–1250
and, 928 Restrictive cardiomyopathy, 198 ischemic digits, 1247
Renal tubular acidosis, 972–973 Restrictive disease of respiratory system, lung infiltrates and elevated sedimentation
acid-base balance and, 972–973 513–520 rate, 1247
Renal vasodilators in acute renal failure, acute cardiopulmonary failure, 515 lung infiltrates in renal failure, 1246
930–931, 930f etiology, 515–516 multiple autoantibodies and multisystem
Renal vein thrombosis, 922 hemodynamic management of, 516 inflammatory disease, 1245
Reperfusion therapy, 307 intubation and mechanical ventilation, outcomes of patients with rheumatologic
Rescue therapies for life-threatening 516–517 diseases in, 1245
hypoxia minimizing ventilator- long-term management of, 517 polymyositis/dermatomyositis, 1244
induced lung injury, noninvasive ventilation, 516 rheumatoid arthritis, 1244–1245
447–448, 448f outcome, 515 scleroderma, 1243–1244
Research concepts relevant to quality oxygen therapy, 516 systemic lupus erythematosus,
measurement, 9–10, 9t pulmonary fibrosis, 517–520 1242–1243
bias in, 9, 9t acute cardiopulmonary failure, 518 use of corticosteroids, immunosuppressives
chance in, 9, 9t cardiovascular management and anti-inflammatory drugs in
confounding measures in, 9t, 10 of, 519 critically ill patient, 1250–1253

Index.indd 1353 23-01-2015 15:33:53